Navigation Links
Global Biosimilars Market - Products, Applications and Regulations
Date:3/15/2013

DUBLIN, March 15, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Biosimilars Market - Products, Applications and Regulations" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19.4bn by 2018

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position is expected to be challenged over the next ten years, since the rapid growth forecast for the biosimilars market has attracted several new companies to enter this lucrative arena. Current leaders, in order to maintain market share, need to introduce new biosimilars over the next few years with a specific focus on the products in demand. Licensing deals are expected to expand the pipelines of established players, as well as new market entrants.

The global biosimilar market, estimated at US$2 billion in 2012 and expected to touch US$2.7 billion in 2013, is further projected to reach US$19.4 billion by 2018, exhibiting a CAGR of 36.6% over 2009-2018. This growth can be attributed to some of the top-selling biologics coming off-patent over the coming few years and biosimilar manufacturers are bound to make a beeline towards this lucrative opportunity.

Publication Overview

This report reviews, analyzes and projects the biosimilars market for global and regional markets including the United States, Europe, Asia-Pacific and Rest of World. The market numbers illustrated in this report only represent the market exclusively for the product segments and application areas enunciated above. The regional markets further analyzed for 8 more independent countries across Europe - France, Germany, Italy, Spain, the United Kingdom and Rest of Europe; Asia-Pacific - China, India, South Korea and Rest of Asia-Pacific.

The market for application areas of biosimilars analyzed in this study includes Blood Disorders, Chronic Diseases, Growth Hormone Deficiency, Oncology and Others. The report also encompasses the market analysis for product segments - Monoclonal Antibodies, Erythropoietin, Human Growth Hormone, Insulin, G-CSF, Interferons and Others.

This 354 page global market report includes 149 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, application area and product segment.The report covers the brief business profiles of 43 key global players and 54 major players across the United States - 13; Europe - 18; Asia-Pacific - 19 and Rest of World - 4. The report also provides the listing of the companies engaged in research and development, manufacturing, processing, supplies and distribution of biosimilars. Also enlisting the academic institutions and industry associations engaged in biosimilars, the global list covers the addresses, contact numbers and the website addresses of 168 companies.

Key Topics Covered: 
Part A: Global Market Perspective

1. Introduction
2. Biosimilar Applications - A Snapshot
3. Regulatory Landscape
4. Key Market Trends
5. Key Global Players
6. Key Business Trends
7. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. The United States
2. Europe
3. Asia-Pacific
4. Rest Of World

Part C: Guide To The Industry

1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World

Part D: Annexure
1. Research Methodology
2. The Questionnaire
3. Feedback
Charts & Graphs
Examples of Companies Mentioned

- 3SBio
- Amgen
- Astrazeneca
- Baxter International
- Biocon
- Biogen IDEC
- Bioton
- Cadila Healthcare
- Celltrion
- Daiichi Sankyo Company
- DSM Biologics
- GE Healthcare
- Glaxosmithkline
- iBio
- Merck
- Mitsubishi Tanabe Pharma Corporation
- Mylan
- Novartis
- Perkinelmer
- Pfizer Inc
- Roche Holding
- Samsung Biologics
- Sandoz International
- Sanofi
- Shantha Biotechnics
- Watson Pharmaceuticals
- Wockhardt Limited


For more information visit http://www.researchandmarkets.com/research/xn2btj/global

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Probiotics Industry
2. Global Blood Processing Supplies And Equipment Industry
3. Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast
4. Perrigo Company To Present At The Barclays Global Healthcare Conference
5. Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
6. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
7. Global Insulin Antidiabetics Market 2012-2016
8. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
9. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
10. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
11. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Jan 20, 2017 Research and Markets ... Market Trends, Opportunities, and Future" report to their offering. ... This research service ... trends, and technologies, and provides a snapshot of the key participants ... and forecasts are provided from 2016 to 2020. The market is ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery Devices ... the Germany Cataract Surgery Devices market. The report provides ... and average prices (USD) within market segements - Phacoemulsification ... also provides company shares and distribution shares data for ...
(Date:1/19/2017)... Call and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) ... for the fourth quarter of 2016 on Wednesday, February 15, 2017, ... ... ET on Wednesday, February 15, 2017, during which management will discuss ... corporate activities. To participate in the conference call, please dial 1-888-771-4371 ...
Breaking Medicine Technology:
(Date:1/23/2017)... ARLINGTON, VA (PRWEB) , ... ... ... Seafood Nutrition Partnership (SNP) has launched online education programs and resources at ... health and nutritional benefits of a seafood-rich diet. These resources have been ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of Christ”: a ... Characteristics of Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, ... thirteen years, a preacher for over nineteen, a pastor for over fifteen years. He ...
(Date:1/22/2017)... (PRWEB) , ... January 22, 2017 , ... Phytocéane invites ... isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the ... key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, ...
(Date:1/22/2017)... ... 22, 2017 , ... "Photo Cloud allows FCPX users to add favorited photos ... complete ease," said Christina Austin - CEO of Pixel Film Studios. , To ... timeline. Presets include scenes with one, three, four or five focus points. There ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company known for ... Show in Hilton Head, SC, where it benefited from outstanding meetings with major retail ... beauty and wellness products. At this trade show, the company had the chance to ...
Breaking Medicine News(10 mins):